HCA Holdings (HCA) Tops Q4 EPS by 8c, Offers Guidance, Approves $10B Buyback
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Mizuho Reiterates Outperform Rating on HCA Healthcare Inc (HCA)
January 27, 2025 11:46 AM ESTMizuho analyst Ann Hynes reiterated an Outperform rating and $425.00 price target on HCA Healthcare Inc (NYSE: HCA).
The analyst comments "We are maintaining our price target of $425, and our 2025E-2026E adjusted EBITDA estimates, while increasing our 2025E-2026E adjusted EPS estimates driven by... More
HCA Healthcare Inc (HCA) PT Lowered to $404 at Leerink Partners
January 27, 2025 6:23 AM ESTLeerink Partners analyst Whit Mayo lowered the price target on HCA Healthcare Inc (NYSE: HCA) to $404.00 (from $460.00) while maintaining a Outperform rating.
The analyst comments "Bottom Line: Reiterate Outperform rating. 4Q24 results brought forth a continuation of strong demand trends, good cost controls and... More
